| Since the last edition of Kalorama Information's DNA | | | | Forecast of Sequencer Revenues to 2014 |
| Sequencing Equipment and Services report, the | | | | Review of Important Sequencers and Comparison of |
| market has been changing in unpredictable ways as | | | | Features and Drawbacks. |
| second-generation sequencers are being incrementally | | | | Profiles of Major Companies in the Marketplace |
| introduced and upgraded. On the surface, the situation | | | | Affymetrix and Illumina Settlement and other Significant |
| has become somewhat linear and predictable, but as | | | | Litigation in the Industry |
| Kalorama Information biotech analyst Justin Saeks | | | | Major Industry Deals since 2008, Review of Deals |
| explains, it is actually a unique and relatively volatile | | | | 05-07, and Analyst Commentary |
| situation that is not seen often with life science tools | | | | Over 70 Figures and Tables making market |
| markets. Third-generation systems have the potential | | | | information accessible |
| to completely change the market, or to simply join the | | | | Review of Major Deals and Litigation affecting the |
| pack. | | | | marketplace. |
| Revenue growth has been unusually high, and all of the | | | | Review of Technologies Under Development |
| trends seem to indicate that growth will continue in the | | | | Discussion of Funding Sources and Recent Grant |
| near term. It is likely that completely new technologies | | | | Awardees |
| will be introduced at least every year or two, while | | | | Strategic Recommendations for Companies Operating |
| second-generation sequencer improvements also | | | | in the DNA Sequencing Market |
| continue. In Kalorama Information biotech analyst Justin | | | | Kalorama Information's DNA Sequencing Equipment |
| Saek's 2nd edition of DNA Sequencing Equipment and | | | | and Service Markets represents research culled from |
| Services Markets, these changes are detailed and put | | | | a variety of secondary sources. But the true insights |
| in context, along with the following: | | | | originated from interviews with market experts; these |
| DNA Sequencer Revenues by Industry and by | | | | interviews were used to confirm numbers and test |
| Leading Systems | | | | forecast assumptions. |